166 related articles for article (PubMed ID: 32509163)
1. Melatonin ameliorates hyperglycaemia-induced renal inflammation by inhibiting the activation of TLR4 and TGF-β1/Smad3 signalling pathway.
Wei J; Wang Y; Qi X; Fan Z; Wu Y
Am J Transl Res; 2020; 12(5):1584-1599. PubMed ID: 32509163
[TBL] [Abstract][Full Text] [Related]
2. Melatonin Ameliorates Renal Fibrosis Through the Inhibition of NF-κB and TGF-β1/Smad3 Pathways in db/db Diabetic Mice.
Fan Z; Qi X; Yang W; Xia L; Wu Y
Arch Med Res; 2020 Aug; 51(6):524-534. PubMed ID: 32473749
[TBL] [Abstract][Full Text] [Related]
3. Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice.
Wu JS; Shi R; Lu X; Ma YM; Cheng NN
PLoS One; 2015; 10(3):e0122661. PubMed ID: 25803610
[TBL] [Abstract][Full Text] [Related]
4. Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy.
Zheng ZC; Zhu W; Lei L; Liu XQ; Wu YG
Drug Des Devel Ther; 2020; 14():4135-4148. PubMed ID: 33116403
[TBL] [Abstract][Full Text] [Related]
5. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
6. Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation.
Wu W; Wang Y; Li H; Chen H; Shen J
Chin Med; 2021 Nov; 16(1):118. PubMed ID: 34775979
[TBL] [Abstract][Full Text] [Related]
7. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
8.
Chen Y; Lin X; Zheng Y; Yu W; Lin F; Zhang J
Evid Based Complement Alternat Med; 2021; 2021():9931983. PubMed ID: 34630622
[No Abstract] [Full Text] [Related]
9. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
Lang H; Dai C
Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
Xu BH; Sheng J; You YK; Huang XR; Ma RCW; Wang Q; Lan HY
Metabolism; 2020 Feb; 103():154013. PubMed ID: 31734275
[TBL] [Abstract][Full Text] [Related]
11. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
12. Oxymatrine inhibits renal fibrosis of obstructive nephropathy by downregulating the TGF-β1-Smad3 pathway.
Wang HW; Shi L; Xu YP; Qin XY; Wang QZ
Ren Fail; 2016 Jul; 38(6):945-51. PubMed ID: 27050799
[TBL] [Abstract][Full Text] [Related]
13. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
[TBL] [Abstract][Full Text] [Related]
14. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway.
Al-Rasheed NM; Al-Rasheed NM; Al-Amin MA; Hasan IH; Al-Ajmi HN; Mohammad RA; Attia HA
Arch Physiol Biochem; 2016 Oct; 122(4):186-194. PubMed ID: 26959841
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effect of berberine on type 2 diabetic nephropathy in rats.
Sun SF; Zhao TT; Zhang HJ; Huang XR; Zhang WK; Zhang L; Yan MH; Dong X; Wang H; Wen YM; Pan XP; Lan HY; Li P
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):662-70. PubMed ID: 25867602
[TBL] [Abstract][Full Text] [Related]
18. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
19. The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-β1 signaling pathway.
Yao Y; Yang J; Wang D; Zhou F; Cai X; Lu W; Hu C; Gu Z; Qian S; Guan X; Cao P
Phytomedicine; 2013 Oct; 20(13):1160-7. PubMed ID: 23827664
[TBL] [Abstract][Full Text] [Related]
20. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
